{"pmid": "12448660", "sentences": {"sent_1": {"Section": "", "text": "PATIENTS AND METHODS : Eligibility included cytologically or pathologically verified diagnosis of colorectal cancer that recurred during or within 12 months of completion of adjuvant therapy , representing patients generally considered resistant to fluorinated pyrimidine therapy .", "entities": {"entity_1": {"text": "pathologically verified diagnosis of colorectal cancer", "class": "Participant", "negation": 0, "UMLS": "C0009402:colorectal cancer,C0011900:diagnosis,C3834725:verified:,", "index": 1, "start": 8}, "entity_2": {"text": "adjuvant therapy", "class": "Participant", "negation": 0, "UMLS": "C0677850:adjuvant therapy,", "index": 2, "start": 24}, "entity_3": {"text": "resistant", "class": "Outcome", "negation": 0, "UMLS": "", "index": 3, "start": 31}, "entity_4": {"text": "fluorinated pyrimidine therapy", "class": "Participant", "negation": 0, "UMLS": "C0087111:therapy,", "index": 4, "start": 33}}, "relations": {}}, "sent_2": {"Section": "", "text": "Stratification was into two cohorts : recurrence while receiving adjuvant therapy , and relapse within 12 months of completing adjuvant therapy .", "entities": {"entity_5": {"text": "recurrence", "class": "Outcome", "negation": 0, "UMLS": "C1458156:recurrence,", "index": 1, "start": 6}, "entity_6": {"text": "adjuvant therapy", "class": "Intervention", "negation": 0, "UMLS": "C0677850:adjuvant therapy,", "index": 2, "start": 9}, "entity_7": {"text": "relapse", "class": "Outcome", "negation": 0, "UMLS": "C0277556:relapse,", "index": 3, "start": 13}}, "relations": {}}, "sent_3": {"Section": "", "text": "Treatment consisted of 28 days of oral therapy every five weeks with eniluracil and 5 - FU administered in a 10:1 ratio .", "entities": {"attribute_1": {"text": "28 days", "class": "measure", "negation": 0, "UMLS": "", "index": 1, "start": 3}, "entity_8": {"text": "oral therapy", "class": "Intervention", "negation": 0, "UMLS": "C0087111:therapy,", "index": 2, "start": 6}, "entity_9": {"text": "eniluracil", "class": "Intervention", "negation": 0, "UMLS": "C0098361:eniluracil,", "index": 3, "start": 12}, "entity_10": {"text": "5 - FU", "class": "Intervention", "negation": 0, "UMLS": "", "index": 4, "start": 14}}, "relations": {}}, "sent_4": {"Section": "", "text": "The daily dose of eniluracil was 10 mg / m 2 with 5 - FU 1 mg / m2 , divided into two doses .", "entities": {"entity_11": {"text": "daily dose of eniluracil", "class": "Intervention", "negation": 0, "UMLS": "C0098361:eniluracil,", "index": 1, "start": 1}, "attribute_2": {"text": "10 mg", "class": "measure", "negation": 0, "UMLS": "", "index": 2, "start": 6}, "entity_12": {"text": "FU 1 mg / m2", "class": "Intervention", "negation": 0, "UMLS": "", "index": 3, "start": 14}, "attribute_3": {"text": "1 mg / m2", "class": "measure", "negation": 0, "UMLS": "", "index": 4, "start": 15}}, "relations": {}}}}